Lotus Bio-Technology Development's common stock is $830.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for LBTD is $830 as of December 2017. That compares with $830 in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Lotus Bio-Technology Development's historical trend and sector peers before judging valuation or financial health.
Over the past year, LBTD's common stock moved from $830 to $830 — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lotus Bio-Technology Development's operating scale or balance-sheet position.
A common stock figure of $830 for LBTD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting LBTD's common stock ($830), review year-over-year change from $830, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.